atorvastatin, Lipitor
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Hypercholesteremia
Conditions
Hypercholesteremia, Coronary Artery Disease
Trial Timeline
— → —
NCT ID
NCT00408382About atorvastatin, Lipitor
atorvastatin, Lipitor is a approved stage product being developed by Astellas Pharma for Hypercholesteremia. The current trial status is completed. This product is registered under clinical trial identifier NCT00408382. Target conditions include Hypercholesteremia, Coronary Artery Disease.
What happened to similar drugs?
1 of 4 similar drugs in Hypercholesteremia were approved
Approved (1) Terminated (0) Active (3)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00408382 | Approved | Completed |
Competing Products
5 competing products in Hypercholesteremia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Rosuvastatin + HMG CoA inhibitor | Shionogi | Approved | 43 |
| SHR-1209 + Placebo | Jiangsu Hengrui Medicine | Phase 1 | 29 |
| Rosuvastatin calcium | AstraZeneca | Phase 3 | 40 |
| Rosuvastatin + Atorvastatin | AstraZeneca | Phase 3 | 40 |
| MK-0524A + ER Niacin + Placebo | Merck | Phase 3 | 40 |